Cargando…

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future

Detalles Bibliográficos
Autores principales:	Lehmann, Sylvain, Teunissen, Charlotte Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037231/ https://www.ncbi.nlm.nih.gov/pubmed/27729897 http://dx.doi.org/10.3389/fneur.2016.00158

Ejemplares similares

Editorial: Trends in biomarkers for neurodegenerative diseases: Current research and future perspectives
por: Dutta, Suman, et al.
Publicado: (2023)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Editorial: Immunological Mechanisms, Biomarkers and Immunotherapies of Alzheimer's Disease
por: Xin, Jia-yan, et al.
Publicado: (2021)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
por: Belbin, Olivia, et al.
Publicado: (2020)

Network-Based Biomarkers in Alzheimer’s Disease: Review and Future Directions
por: Gomez-Ramirez, Jaime, et al.
Publicado: (2014)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)

Editorial: Alzheimer's Disease and the Fornix
por: Oishi, Kenichi, et al.
Publicado: (2016)

Editorial: The Alzheimer's Disease Challenge
por: Alexiou, Athanasios, et al.
Publicado: (2019)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
por: Zhan, Yu, et al.
Publicado: (2023)

Editorial: SLC6A1: the past, present and future
por: Johannesen, Katrine M., et al.
Publicado: (2023)

Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities
por: Ovais, Muhammad, et al.
Publicado: (2018)

Editorial: Neurophysiology in Alzheimer's Disease and Dementia
por: Moretti, Davide V.
Publicado: (2016)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

Editorial: Nutrition and prevention of Alzheimer's disease
por: Perez-Cruz, Claudia, et al.
Publicado: (2015)

Editorial: Risk Factors for Alzheimer's Disease
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2020)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Editorial: Myelin-Mediated Inhibition of Axonal Regeneration: Past, Present, and Future
por: Hannila, Sari, et al.
Publicado: (2017)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Editorial: The Alzheimer's disease challenge, volume II
por: Kamal, Mohammad Amjad, et al.
Publicado: (2023)

An atlas on biomarkers for Alzheimer's disease
por: Martínez-Rivera, Marta
Publicado: (2013)

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
por: Prins, Samantha, et al.
Publicado: (2022)

The Eye As a Biomarker for Alzheimer's Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2016)

Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
por: Yu, Tingting, et al.
Publicado: (2021)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Editorial: ICT for Assessment and Rehabilitation in Alzheimer’s Disease and Related Disorders
por: Robert, Philippe, et al.
Publicado: (2016)

Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease
por: Giannoni, Patrizia, et al.
Publicado: (2020)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
por: Hillen, Heinz
Publicado: (2023)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

Ophthalmic Biomarkers for Alzheimer’s Disease: A Review
por: Majeed, Ayesha, et al.
Publicado: (2021)

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease
por: Pons, Marie-Laure, et al.
Publicado: (2022)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Editorial: Improving memory deficits in Alzheimer's disease
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias
por: Ibáñez, Agustín, et al.
Publicado: (2022)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

Editorial: Deafness, aging and Alzheimer's disease: Neurobiological links and therapy options
por: Juiz, José M., et al.
Publicado: (2023)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8k8ednqnl5s971a8ortufjbc2